IHE ETF (iShares US Pharmaceutical ETF) is managed by iShares by BlackRock (US) with $1.02B in net assets. IHE expense ratio is 0.38%, holding 59 positions across sectors including Health Care, Unknown, Consumer Staples. Inception date: 2006-05-01.

IHE performance shows a YTD return of 8.26%. The 1-year return is 26.91% and the 5-year return is 10.62%. IHE dividend yield stands at 1.63%, paid quarterly.

IHE top holdings include Eli Lilly & Co (23.9%), Johnson & Johnson (22.0%), Merck & Company Inc (4.8%), Zoetis Inc, Class A (4.7%), Bristol-Myer Sq (4.6%). View all IHE holdings, sector breakdown, or dividend history.

IHE can be compared against other funds using the overlap calculator or side-by-side comparison tool. IHE alternatives are available via the screener, along with tax-loss harvesting opportunities.